| |
| |
|
| Insider
Information: |
Kisner Daniel L |
| Relationship: |
|
| City: |
Hopkinton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
207,405 |
|
|
Indirect Shares
|
30,455 |
|
|
| Direct
Value |
$873,756 |
|
|
|
Indirect Value
|
$165,467 |
|
|
| Total
Shares |
237,860 |
|
|
| Total
Value |
$1,039,223 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 153.2%
|
224.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Caliper Life Sciences Inc |
CALP |
Former Director |
2008-06-03 |
108,101 |
2008-04-14 |
0 |
Premium* |
|
|
Dynavax Technologies Corp |
DVAX |
Director |
2023-05-26 |
12,214 |
2013-10-30 |
15,000 |
Premium* |
|
|
Apollo Endosurgery, Inc |
APEN |
Director |
2012-07-30 |
70,590 |
2012-07-30 |
0 |
Premium* |
|
|
Histogen Inc |
HSTO |
Director |
2016-12-28 |
4,000 |
2016-12-28 |
5,455 |
Premium* |
|
|
Tekmira Pharmaceuticals Corp |
TKMR |
Director |
2015-01-01 |
12,500 |
|
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Director |
2020-07-21 |
0 |
2020-07-21 |
10,000 |
Premium* |
|
|
Zynerba Pharmaceuticals, Inc. |
ZYNE |
|
2023-10-10 |
0 |
2021-08-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZYNE |
Zynerba Pharmaceuticals, ... |
|
• • – |
2023-10-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(75,778) |
0 |
0 |
- |
|
| HSTO |
Histogen Inc |
Director |
– • – |
2014-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,145 |
3,145 |
0 |
- |
|
| HSTO |
Histogen Inc |
Director |
– • – |
2014-02-19 |
4/A |
A |
$0.00 |
$0 |
I/I |
3,145 |
3,145 |
0 |
- |
|
| DVAX |
Dynavax Technologies Corp |
Director |
– • – |
2012-01-26 |
4 |
OE |
$2.02 |
$10,100 |
I/I |
5,000 |
5,000 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| HSTO |
Histogen Inc |
Director |
– • – |
2016-12-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,310 |
5,455 |
0 |
- |
|
| HSTO |
Histogen Inc |
Director |
– • – |
2015-04-08 |
4 |
B |
$5.75 |
$23,000 |
D/D |
4,000 |
7,145 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2020-07-21 |
4 |
B |
$2.38 |
$23,825 |
I/I |
10,000 |
10,000 |
2.1 |
% |
|
| DVAX |
Dynavax Technologies Corp |
Director |
– • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,357 |
12,214 |
0 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Director |
– • – |
2015-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,500 |
|
- |
|
| DVAX |
Dynavax Technologies Corp |
Director |
– • – |
2013-10-30 |
4 |
B |
$1.08 |
$10,750 |
I/I |
10,000 |
15,000 |
2.1 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2022-06-14 |
4 |
S |
$1.01 |
$40 |
D/D |
(40) |
28,069 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,109 |
28,109 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2012-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
70,590 |
70,590 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2023-06-14 |
4 |
S |
$0.35 |
$40 |
D/D |
(115) |
75,778 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
47,824 |
75,893 |
0 |
- |
|
| CALP |
Caliper Life Sciences Inc |
Director |
– • – |
2008-04-14 |
4 |
S |
$3.60 |
$49,916 |
D/D |
(13,700) |
108,101 |
0 |
- |
|
| CALP |
Caliper Life Sciences Inc |
Director |
– • – |
2008-04-15 |
4 |
S |
$3.60 |
$21,955 |
D/D |
(6,000) |
108,101 |
0 |
- |
|
| CALP |
Caliper Life Sciences Inc |
Director |
– • – |
2008-04-16 |
4 |
S |
$3.55 |
$19,075 |
D/D |
(5,300) |
108,101 |
0 |
- |
|
| CALP |
Caliper Life Sciences Inc |
Director |
– • – |
2008-05-01 |
4 |
S |
$3.57 |
$21,067 |
D/D |
(5,800) |
108,101 |
0 |
- |
|
| CALP |
Caliper Life Sciences Inc |
Director |
– • – |
2008-05-02 |
4 |
S |
$3.54 |
$34,208 |
D/D |
(9,600) |
108,101 |
0 |
- |
|
| CALP |
Caliper Life Sciences Inc |
Director |
– • – |
2008-05-05 |
4 |
S |
$3.50 |
$23,137 |
D/D |
(6,583) |
108,101 |
0 |
- |
|
| CALP |
Caliper Life Sciences Inc |
Director |
– • – |
2008-05-06 |
4 |
S |
$3.50 |
$8,412 |
D/D |
(2,400) |
108,101 |
0 |
- |
|
| CALP |
Caliper Life Sciences Inc |
Director |
– • – |
2008-05-13 |
4 |
S |
$3.50 |
$2,160 |
D/D |
(617) |
108,101 |
0 |
- |
|
| CALP |
Caliper Life Sciences Inc |
Director |
– • – |
2008-05-16 |
4 |
S |
$3.50 |
$10,776 |
D/D |
(3,078) |
108,101 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
